Executive Director, Clinical QA
Neurocrine Biosciences
About this role
Senior leadership role at Neurocrine Biosciences responsible for leading the Clinical Quality Assurance organization. The position focuses on defining strategy and operating plans for clinical quality, maintaining compliance with global regulatory standards, and representing the company in regulatory interactions. It is a people-leadership role aimed at building and sustaining a quality-focused organization that supports clinical development.
Skills
Qualifications
About Neurocrine Biosciences
neurocrine.comN/A
Recent company news
PR NewswireNeurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
MarketBeatMagnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Simply Wall StIs It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
MarketBeatCapital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
MeykaCantor Fitzgerald Keeps Overweight on NBIX Neurocrine Biosciences March 2026
1 day ago
About Neurocrine Biosciences
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
Salary
$246k – $336k
per year
More jobs at Neurocrine Biosciences
Similar Jobs
Executive Director, Clinical Quality Assurance
Jade Biosciences
Executive Director, Research & Clinical Development QA
Sarepta Therapeutics
Executive Director, Clinical Data Science
Eisai
Executive Director, Clinical Operations
Therapeuticsinc
Associate Director, Clinical QA
Diversity Employment
Executive Medical Director, Clinical Development CV/Renal/Metabolism
Regeneron Pharmaceuticals